Botox patch for raynaud's in scleroderma
Part of Skin clinical trials.
This study tests a special patch with tiny needles that deliver botulinum toxin (botox) into the skin to treat Raynaud's symptoms in people with scleroderma. It may help reduce pain and improve blood flow in fingers and toes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with scleroderma (an autoimmune disease that causes skin and organ hardening) and have Raynaud's (fingers/toes turning white or blue in cold)
- You can read, write, and understand Thai
- You are not currently using a cream containing isosorbide dinitrate (ISDN) for Raynaud's
- You are not taking medications that narrow blood vessels (like beta-blockers or ergotamine)
- You do not have certain conditions that could interfere, like active infections, pregnancy, or a recent hand surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
This trial tests if a device called Apollo can help reduce fatigue and Raynaud's symptoms and improve quality of life in people with scleroderma (systemic sclerosis). You would use the device at home and track your symptoms using a smartphone app.
This study looks at how a new drug affects skin scarring (fibrosis) in people with systemic sclerosis (SSc), a rare autoimmune disease. It aims to understand if this drug can help reduce the skin thickening and immune changes caused by SSc.
This trial tests if a CBD (cannabidiol) lotion can help reduce itching in people with scleroderma, a condition that often causes chronic itch. It compares the CBD lotion to a placebo (inactive lotion) to see if it works and is safe.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study tests a new medicine (called GB261) given as an infusion for people with systemicsclerosis (scleroderma) that affects the skin widely. The goal is to see if it can reduce skin thickening and improve symptoms.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.